Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Preclinical Study of 18F-ML-10 to Evaluate Early Target Therapy Response of Novel MDM2-p53 Antagonist APG115 in Dedifferentiated Papillary Thyroid Carcinoma: A Comparison with 18F-FDG PET

Haibo Chen, Zhou Gao, Shu Hu, Hongjie Yang, Xiaohua Lin, Dajun Yang and Ningyi Jiang
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1130;
Haibo Chen
1Peking University Shenzhen Hospital Shenzhen China
2Peking University Shenzhen Hospital Shenzhen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhou Gao
1Peking University Shenzhen Hospital Shenzhen China
2Peking University Shenzhen Hospital Shenzhen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu Hu
1Peking University Shenzhen Hospital Shenzhen China
2Peking University Shenzhen Hospital Shenzhen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongjie Yang
1Peking University Shenzhen Hospital Shenzhen China
2Peking University Shenzhen Hospital Shenzhen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaohua Lin
1Peking University Shenzhen Hospital Shenzhen China
2Peking University Shenzhen Hospital Shenzhen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dajun Yang
4Sun Yat-sen University Cancer Center Guangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ningyi Jiang
3Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 59 no. supplement 1 1130

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 23, 2018.

Copyright & Usage 
© 2018

Author Information

  1. Haibo Chen1,2,
  2. Zhou Gao1,2,
  3. Shu Hu1,2,
  4. Hongjie Yang1,2,
  5. Xiaohua Lin1,2,
  6. Dajun Yang4 and
  7. Ningyi Jiang3
  1. 1Peking University Shenzhen Hospital Shenzhen China
  2. 2Peking University Shenzhen Hospital Shenzhen China
  3. 3Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou China
  4. 4Sun Yat-sen University Cancer Center Guangzhou China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2018 to April 2025

AbstractFullPdf
May 2018400
Jun 20182200
Jul 20182100
Aug 2018400
Sep 2018600
Oct 20181800
Nov 20181900
Dec 20181700
Jan 20191000
Feb 20191500
Mar 20193200
Apr 20191800
May 2019600
Jun 2019500
Jul 2019500
Aug 2019700
Sep 2019100
Oct 2019100
Jan 20201100
Feb 20201000
Mar 20201500
Apr 2020700
May 2020500
Jun 2020100
Aug 2020100
Sep 20201600
Oct 20201700
Nov 20201100
Dec 20201400
Jan 2021400
Feb 20211300
Mar 2021800
Apr 20211200
May 2021800
Jun 2021500
Jul 20211000
Aug 20212300
Sep 20211200
Oct 20211000
Nov 20214300
Dec 20212500
Jan 20224700
Feb 20221300
Mar 20222500
Apr 2022900
May 20221700
Jun 2022300
Jul 2022200
Aug 2022400
Sep 2022100
Oct 2022100
Nov 2022200
Dec 2022300
Jan 2023300
Feb 2023500
Mar 2023200
Apr 2023200
May 2023200
Jun 2023200
Jul 2023200
Aug 2023400
Sep 2023400
Oct 2023400
Nov 2023300
Dec 2023100
Jan 2024500
Feb 2024400
Mar 2024400
Apr 2024200
May 2024400
Jun 2024200
Jul 2024200
Aug 20241000
Sep 2024500
Oct 2024100
Nov 2024100
Dec 2024300
Jan 2025200
Feb 2025400
Mar 2025500
Apr 2025200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical Study of 18F-ML-10 to Evaluate Early Target Therapy Response of Novel MDM2-p53 Antagonist APG115 in Dedifferentiated Papillary Thyroid Carcinoma: A Comparison with 18F-FDG PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical Study of 18F-ML-10 to Evaluate Early Target Therapy Response of Novel MDM2-p53 Antagonist APG115 in Dedifferentiated Papillary Thyroid Carcinoma: A Comparison with 18F-FDG PET
Haibo Chen, Zhou Gao, Shu Hu, Hongjie Yang, Xiaohua Lin, Dajun Yang, Ningyi Jiang
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1130;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical Study of 18F-ML-10 to Evaluate Early Target Therapy Response of Novel MDM2-p53 Antagonist APG115 in Dedifferentiated Papillary Thyroid Carcinoma: A Comparison with 18F-FDG PET
Haibo Chen, Zhou Gao, Shu Hu, Hongjie Yang, Xiaohua Lin, Dajun Yang, Ningyi Jiang
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1130;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Preclinical Probes for Oncology Posters

  • Targeted molecular imaging of c-Met in NSCLC using 68Ga-labeled binding peptide
  • A Next Generation Theranostic PSMA Ligand for 64Cu and67Cu-Based Prostate Cancer Imaging and Therapy
  • A new PET imaging agent for monitoring HER2 status using Trastuzumab antibody conjugated with a novel 89 Zr-chelator.
Show more Preclinical Probes for Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire